272 related articles for article (PubMed ID: 14749494)
1. Essential roles of Her2/erbB2 in cardiac development and function.
Negro A; Brar BK; Lee KF
Recent Prog Horm Res; 2004; 59():1-12. PubMed ID: 14749494
[TBL] [Abstract][Full Text] [Related]
2. ErbB2 is essential in the prevention of dilated cardiomyopathy.
Crone SA; Zhao YY; Fan L; Gu Y; Minamisawa S; Liu Y; Peterson KL; Chen J; Kahn R; Condorelli G; Ross J; Chien KR; Lee KF
Nat Med; 2002 May; 8(5):459-65. PubMed ID: 11984589
[TBL] [Abstract][Full Text] [Related]
3. Requirement for neuregulin receptor erbB2 in neural and cardiac development.
Lee KF; Simon H; Chen H; Bates B; Hung MC; Hauser C
Nature; 1995 Nov; 378(6555):394-8. PubMed ID: 7477377
[TBL] [Abstract][Full Text] [Related]
4. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
5. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
6. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy.
Ozcelik C; Erdmann B; Pilz B; Wettschureck N; Britsch S; Hübner N; Chien KR; Birchmeier C; Garratt AN
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8880-5. PubMed ID: 12072561
[TBL] [Abstract][Full Text] [Related]
7. ErbB2 pathways in heart and neural diseases.
Garratt AN; Ozcelik C; Birchmeier C
Trends Cardiovasc Med; 2003 Feb; 13(2):80-6. PubMed ID: 12586444
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
Schneider JW; Chang AY; Rocco TP
Semin Oncol; 2001 Oct; 28(5 Suppl 16):18-26. PubMed ID: 11706392
[TBL] [Abstract][Full Text] [Related]
10. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
[TBL] [Abstract][Full Text] [Related]
12. Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart.
Campreciós G; Lorita J; Pardina E; Peinado-Onsurbe J; Soley M; Ramírez I
J Cell Physiol; 2011 Feb; 226(2):450-5. PubMed ID: 20672328
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.
Fedele C; Riccio G; Malara AE; D'Alessio G; De Lorenzo C
Breast Cancer Res Treat; 2012 Jul; 134(2):595-602. PubMed ID: 22674190
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
[TBL] [Abstract][Full Text] [Related]
15. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system.
Britsch S; Li L; Kirchhoff S; Theuring F; Brinkmann V; Birchmeier C; Riethmacher D
Genes Dev; 1998 Jun; 12(12):1825-36. PubMed ID: 9637684
[TBL] [Abstract][Full Text] [Related]
16. BACE1 dependent neuregulin processing: review.
Fleck D; Garratt AN; Haass C; Willem M
Curr Alzheimer Res; 2012 Feb; 9(2):178-83. PubMed ID: 22455478
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
18. Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review.
Patnaik SK; Chandrasekar MJN; Nagarjuna P; Ramamurthi D; Swaroop AK
Mini Rev Med Chem; 2022 Oct; 22(22):2831-2846. PubMed ID: 35549881
[TBL] [Abstract][Full Text] [Related]
19. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
